Sign in
Taking people in United StatesNo phase

Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOT

Key facts

Who runs it
University of Pennsylvania
Where
Philadelphia, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
20 people, planned
Started
1 Jan 2026
Expected to end
31 May 2027
Type of study
Interventional
Treatments tested
  • Penny COPILOT
Record updated
28 July 2026

Who can take part

Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Biological females who are currently pregnant or within 6 weeks postpartum
  • Able to read, write, and speak English at a 6th grade level
  • Diagnosed and receiving treatment for, or willing to receive treatment for opioid use disorder
  • Receiving prenatal care and OUD care at a Penn affiliated hospital

Who cannot take part

  • -Current untreated psychosis, mania, or active suicidality as assessed by the Mini International Neuropsychiatric Interview (MINI)

This trial is currently available in United States.

  • Hospital of the University of Pennsylvania (HUP)Philadelphia, United StatesContact: Emma Farber, BATaking people
  • University of PennsylvaniaPhiladelphia, United StatesContact: Sara L Kornfield, PhDNot yet recruiting

About the trial

What the trial wants to find out

To address both loneliness and engagement in perinatal and OUD care among perinatal women, the investigators plan to adapt an existing texting support chatbot, Penny, to make it appropriate for use by women who are pregnant and postpartum and dealing with OUD. The newly adapted chatbot, Penny COPILOT, will allow for two way short message service (SMS) messaging to respond appropriately and accurately to user generated input. The investigative team, in collaboration with the Penn Mixed Methods Research Lab (MMRL) and Penn's Way 2 Health Team, will use intervention mapping guided by the Consolidated Framework for Implementation Science. The investigators will conduct a needs assessment, assemble an advisory board, engage in pretesting to ensure safety and refine content, and pilot test the resultant adapted Penny COPILOT in a sample of 20 perinatal women with OUD to evaluate acceptability, feasibility, and patient satisfaction. The goal is to develop and refine an acceptable, feasible, and satisfactory supportive texting chatbot to promote patient engagement in perinatal and OUD care and decrease perceived loneliness.

The group in the trial

  • Chatbot InterventionTreatment being tested

    This is a single arm study designed to assess the acceptability and feasibility of the chatbot.

    Treatment: Penny COPILOT

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
28 July 2026